DURECT Corporation Price Chart
DURECT Corporation DC8.SG Financial and Trading Overview
DURECT Corporation stock price | 0.0000 EUR |
Previous Close | 0 EUR |
Open | 0.36 EUR |
Bid | 0.35 EUR x 500000 |
Ask | 0.39 EUR x 500000 |
Day's Range | 0 - 0.36 EUR |
52 Week Range | 0 - 5.9 EUR |
Volume | 0 EUR |
Avg. Volume | 200 EUR |
Market Cap | 0 EUR |
Beta (5Y Monthly) | 1.582394 |
PE Ratio (TTM) | 0 |
EPS (TTM) | -0.154 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DC8.SG Valuation Measures
Enterprise Value | 71.31M EUR |
Trailing P/E | 0 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0 |
Price/Book (mrq) | 0 |
Enterprise Value/Revenue | 3.672 |
Enterprise Value/EBITDA | -2.003 |
Trading Information
DURECT Corporation Stock Price History
Beta (5Y Monthly) | 1.582394 |
52-Week Change | -30.00000000000000000000000000000000% |
S&P500 52-Week Change | 20.43% |
52 Week High | 5.9 EUR |
52 Week Low | 0 EUR |
50-Day Moving Average | 4.63 EUR |
200-Day Moving Average | 4.63 EUR |
DC8.SG Share Statistics
Avg. Volume (3 month) | 200 EUR |
Avg. Daily Volume (10-Days) | 291 EUR |
Shares Outstanding | 22.79M |
Float | 20.06M |
Short Ratio | N/A |
% Held by Insiders | 1.49% |
% Held by Institutions | 39.57% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | NaN |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 0.1:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -187.81% |
Operating Margin (ttm) | -184.0079% |
Gross Margin | 85.49% |
EBITDA Margin | -183.34% |
Management Effectiveness
Return on Assets (ttm) | -32.16% |
Return on Equity (ttm) | -115.89% |
Income Statement
Revenue (ttm) | 19.42M EUR |
Revenue Per Share (ttm) | 0.84 EUR |
Quarterly Revenue Growth (yoy) | 7.29% |
Gross Profit (ttm) | 16.48M EUR |
EBITDA | -35609000 EUR |
Net Income Avi to Common (ttm) | -36478000 EUR |
Diluted EPS (ttm) | -0.154 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 44.22M EUR |
Total Cash Per Share (mrq) | 1.81 EUR |
Total Debt (mrq) | 22.96M EUR |
Total Debt/Equity (mrq) | 149.64 EUR |
Current Ratio (mrq) | 1.2 |
Book Value Per Share (mrq) | 0.627 |
Cash Flow Statement
Operating Cash Flow (ttm) | -29984000 EUR |
Levered Free Cash Flow (ttm) | -8930125 EUR |
Profile of DURECT Corporation
Country | Germany |
State | CA |
City | Cupertino |
Address | 10260 Bubb Road |
ZIP | 95014-4166 |
Phone | 408 777 1417 |
Website | https://www.durect.com |
Industry | |
Sector(s) | |
Full Time Employees | 75 |
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Q&A For DURECT Corporation Stock
What is a current DC8.SG stock price?
DURECT Corporation DC8.SG stock price today per share is 0.0000 EUR.
How to purchase DURECT Corporation stock?
You can buy DC8.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DURECT Corporation?
The stock symbol or ticker of DURECT Corporation is DC8.SG.
How many shares does DURECT Corporation have in circulation?
The max supply of DURECT Corporation shares is 0.
What is DURECT Corporation Price to Earnings Ratio (PE Ratio)?
DURECT Corporation PE Ratio is 0.00000000 now.
What was DURECT Corporation earnings per share over the trailing 12 months (TTM)?
DURECT Corporation EPS is -0.154 EUR over the trailing 12 months.